Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Implant2Dentist ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   2.2% 2.2% 2.2% 2.2% 2.2% 2.2% 2.2% 2.2%   Bankruptcy risk   6.5% 3.8% 7.4% 3.2% 8.3% 17.6% 17.3% 17.3%   Credit score (0-100)   38 52 32 54 29 8 9 9   Credit rating   BBB BBB BB BBB BB B BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 -0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   833 1,002 247 1,634 112 -1,545 0.0 0.0   EBITDA   832 1,002 -28.8 1,359 -674 -2,409 0.0 0.0   EBIT   832 1,001 -40.8 1,326 -788 -2,610 0.0 0.0   Pre-tax profit (PTP)   831.2 993.6 -38.0 1,348.6 -766.3 -2,670.7 0.0 0.0   Net earnings   648.4 775.0 -36.0 1,041.3 -597.8 -2,271.5 0.0 0.0   Pre-tax profit without non-rec. items   831 994 -38.0 1,349 -766 -2,671 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   0.0 37.4 192 129 741 705 0.0 0.0   Shareholders equity total   698 1,473 1,437 2,478 1,881 -391 -517 -517   Interest-bearing liabilities   237 2.0 402 0.0 993 2,780 517 517   Balance sheet total (assets)   1,550 2,288 2,420 3,556 3,312 2,808 0.0 0.0   Net Debt   211 -382 142 -89.4 944 2,623 517 517     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   833 1,002 247 1,634 112 -1,545 0.0 0.0   Gross profit growth   124.0% 20.3% -75.3% 561.3% -93.1% 0.0% 0.0% 0.0%   Employees   0 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,550 2,288 2,420 3,556 3,312 2,808 0 0   Balance sheet change%   51.1% 47.6% 5.8% 46.9% -6.9% -15.2% -100.0% 0.0%   Added value   832.1 1,002.1 -28.8 1,359.5 -754.8 -2,409.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 37 143 -97 498 -237 -705 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 -1.0 1.0 -1.0 -2.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   99.9% 99.9% -16.5% 81.2% -703.5% 169.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   64.6% 52.2% -1.2% 45.4% -22.5% -79.9% 0.0% 0.0%   ROI %   104.7% 83.0% -1.7% 62.8% -28.9% -92.1% 0.0% 0.0%   ROE %   173.4% 71.4% -2.5% 53.2% -27.4% -96.9% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   45.1% 64.4% 59.4% 69.7% 56.8% -12.2% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   25.4% -38.1% -493.1% -6.6% -139.9% -108.9% 0.0% 0.0%   Gearing %   33.9% 0.1% 27.9% 0.0% 52.8% -711.3% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.2% 6.6% 5.1% 4.3% -1.6% 3.6% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   0.3 1.0 1.1 1.6 0.5 0.3 0.0 0.0   Current Ratio   1.8 2.8 2.3 3.2 1.8 0.7 0.0 0.0   Cash and cash equivalent   25.5 383.6 259.4 89.4 49.5 157.3 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   698.1 1,437.7 1,233.5 2,346.4 1,128.7 -1,106.9 -258.4 -258.4   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 1,002 -29 1,359 -755 -2,409 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 1,002 -29 1,359 -674 -2,409 0 0   EBIT / employee   0 1,001 -41 1,326 -788 -2,610 0 0   Net earnings / employee   0 775 -36 1,041 -598 -2,271 0 0